The Scientist

» FDA and developmental biology

Most Recent

The Donald Danforth Plant Science Center researcher links complex traits to the genes that underlie them.

0 Comments

image: From the Ground Up

From the Ground Up

By | February 1, 2017

Instrumental in launching Arabidopsis thaliana as a model system, Elliot Meyerowitz has since driven the use of computational modeling to study developmental biology.

0 Comments

image: Science Your Plants!

Science Your Plants!

By | February 1, 2017

CalTech researcher Elliot Meyerowitz describes how plant genetics influences growth and productivity.

1 Comment

image: Marijuana Research Still Stymied by Federal Laws

Marijuana Research Still Stymied by Federal Laws

By | January 23, 2017

US scientists continue to have a hard time getting funding to study the health impacts of the drug. But cannabis research in Canada—where medical marijuana is legal nationwide—is different story.

1 Comment

image: Califf Vacates FDA’s Top Post

Califf Vacates FDA’s Top Post

By | January 20, 2017

Robert Califf steps down as FDA Commissioner as Donald Trump takes office.

0 Comments

image: Drug Approval Timeline Same as 20 Years Ago

Drug Approval Timeline Same as 20 Years Ago

By | January 9, 2017

A report finds that new medications still take about 12 years to go from patent to patient.

0 Comments

Children born to obese parents are at increased risk of failing motor development and cognitive tests, according to an NIH-led study.

0 Comments

image: FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

By | December 28, 2016

The oligonucleotide therapeutic will soon be available in the U.S.

0 Comments

image: Famed Mammalian Embryologist Dies

Famed Mammalian Embryologist Dies

By | December 2, 2016

Andrzej Tarkowski’s research laid the groundwork for future advances in cloning, stem cell research, and in vitro fertilization.

0 Comments

image: FDA OKs Clinical Trials of Ecstasy for PTSD

FDA OKs Clinical Trials of Ecstasy for PTSD

By | December 1, 2016

The illicit drug has shown promise in helping people with debilitating post-traumatic stress disorder.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Stomach Cells Change Identity to Drive Precancerous State
  4. Mutation Linked to Longer Life Span in Men
AAAS